Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Yet More New Developmetn Re; Amarin

|Includes:Amarin Corporation PLC (AMRN), OMTH

IP continues to go AMRN's way. Epanova patent argument rejected by USPTO. Not a typical non-final. It's a thumbs down, prior art response. Epanova has zero composition patents. AZN just wasted a few hundred million bucks.

Stocks: AMRN, OMTH